Cargando…
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
Objective To show non-inferiority of trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of severe infections due to meticillin resistant Staphylococcus aureus (MRSA). Design Parallel, open label, randomised controlled trial. Setting Four acute care hospitals in Israel. Particip...
Autores principales: | Paul, Mical, Bishara, Jihad, Yahav, Dafna, Goldberg, Elad, Neuberger, Ami, Ghanem-Zoubi, Nesrin, Dickstein, Yaakov, Nseir, William, Dan, Michael, Leibovici, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431679/ https://www.ncbi.nlm.nih.gov/pubmed/25977146 http://dx.doi.org/10.1136/bmj.h2219 |
Ejemplares similares
-
External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA
por: Paul, Mical, et al.
Publicado: (2015) -
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
por: Turjeman, Adi, et al.
Publicado: (2021) -
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
por: Paul, Mical, et al.
Publicado: (2023) -
Oral iron supplements for children in malaria‐endemic areas
por: Neuberger, Ami, et al.
Publicado: (2016) -
The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study
por: Yahav, Dafna, et al.
Publicado: (2019)